Member Info for Laura2022

Thanks to PJ yesterday

Spoke to Mark last week and he's hoping to reveal the yet un named nasdaq Co.in a blog THIS WEEK (my emphasis)

Also a new IP formulation to extend 201

PJ

Thanks Ian

I will.do some further research,

KingH

He is a total liar and pest

No jaari888

We're talking about a DIFFERENT thing.. the DoseMeRx one which is ALREADY being integrated for last 6mths

Go away

I remembered you had talked about it

TRENCH123

Posted in: PYC

Posts: 289

Price: 0.70

No Opinion

RE: Worth a listen9 Nov 2024 11:29

Definitely worth a listen

Includes PS comments 'We are making some great progress with our personalised dosing tool .. with one of our partners based in the US, a company called DoseMe, to try and get the tool accessible to clinicians primarily in the US but also across Europe'

The DoseMe customer base extends beyond the US. This is an extract from an announcement made earlier this year with specific reference to Europe : -

"We are thrilled to have successfully navigated the transition to the MDR framework," said Paul Edwards, CEO, DoseMe. "This achievement not only demonstrates our commitment to regulatory excellence but also ensures that our customers and their patients remain protected under the latest European medical device regulations. Our team has worked diligently to meet these requirements, and we are proud to continue providing a safe and compliant solution"

https://doseme-rx.com/en-gb/news-media/article/dosemerx-ce-certificate-for-mdr-onformity

Hi Ianjan

What's the story here please ?

Someone said they have USA helium/hydrogen ?

Many thanks Trench

Didn't Pete specifically mention It in the recent Proactive interview?

Thankyou Basil for that summary of biotech valuations

Why did you then try to promote PYC on the TCF board this morning ?

You're pathetic and your attempts to discredit are too

Stick to your RENX TCF shares where the CEOs are on x 4 PYCs and delivering hardly any revenues (if at all )

For those new to PYC/DOSEMERX this was from June 2024 and then in the recent November 2024 Proactive interview it was confirmed that things are progressing at pace

https://doseme-rx.com/en-gb/news-media/article/physiomics-adds-functionality-to-doseme

He's a expert st saying nothing or U turns

Re joined in Dec 2024 as another new ID

Permanently filtered but no doubt you'll come back as a new ID Santa like your previous 10+

3.22pm: GSK (LON:GSK) cancer M&A

UK pharma giant GSK PLC (LSE:GSK, NYSE:GSK) is close to buying a US biotech, the FT is reporting.

It will pay $1 billion for startup IDRx, which was only founded in 2022, to boost its cancer drug business.

Backed by a raft of venture capital and private equity firms, the Massachusetts-based firm has been developing a treatment for gastrointestinal tumours.

Shows how much the companies are being valued at, this was just a start up company below :

3.22pm: GSK (LON:GSK) cancer M&A

UK pharma giant GSK PLC (LSE:GSK, NYSE:GSK) is close to buying a US biotech, the FT is reporting.

It will pay $1 billion for startup IDRx, which was only founded in 2022, to boost its cancer drug business.

Backed by a raft of venture capital and private equity firms, the Massachusetts-based firm has been developing a treatment for gastrointestinal tumours.

Now they'll keep buying over next 2 weeks

Because you're an insider

The precision application will save time in favour of the patient and hopefully help overall survival.

Naturally saving time and dosing will save significant amounts of money…

Docetaxel market size was valued at USD 114.78 billion in 2023 and it is estimated to reach USD 252.46 billion in 2032.

Currently unable to buy at 0.75

Breaking out as we speak

As you know I sold TIG yesterday for over 50% profit after buying in early Dec

I am tempted by SYS and if anyone could take time to review is I would be grateful

I have no current holdings